Navigation Links
Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
Date:11/21/2007

and other risks related to development, production, and commercialization of cellulosic ethanol and other biofuels and the commercial prospects of those industries, Verenium's dependence on existing collaboration, manufacturing, and/or license agreements, and its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize products (including by obtaining any required regulatory approvals) using Verenium's technologies and timing for launching any commercialized products, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future ability of Verenium to enter into and/or maintain collaboration and joint venture agreements and licenses, changes in the U.S. or global energy markets and risks and other uncertainties more fully described in the Company's filings with the Securities and Exchange Commission, including, but not limited to, the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2007. These forward-looking statements speak only as of the date hereof. The Company expressly disclaims any intent or obligation to update these forward looking statements.

Contacts:

Kelly Lindenboom

Vice President, Corporate Communications

617-674-5335

kelly.lindenboom@verenium.com

Wendy Kelley

IR Specialist

858-526-5437

wendy.kelley@verenium.com


'/>"/>
SOURCE Verenium Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
2. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
3. Verenium Corporation to Present at the Pacific Growth Equities 2007 Clean Technology & Industrial Growth Conference
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
6. Cell Genesys to Present at the Bear Stearns 20th Annual Healthcare Conference
7. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
8. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
9. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
10. Cell Genesys to Present at the BIO Investor Forum
11. Stallergenes : 3rd Quarter Sales Up 17%: 9- Month Cumulative Sales Up 17%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)IRVINE, Calif., Dec. 4 BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company focused on changing the world,s transportation fuel paradigm through the production of ethanol from non-food
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...yrne Chapman, CIO of American Family When Byrne C...ly wasnt one of the variations he imagined. Yet th... taken him in just that direction. Byrne Chapmans ...rm data from the national weather service. , ,They...atch the predictions to the locations of their pol...
... Communications Inc., through its non-profit arm t...y-related grants to Wisconsin non-profits, the Bus...ty-four organizations that provide social services...ived money to help them use more technology. The g...ich typically gives from $2,500 to $25,000 per org...
...eres a great thing about the tech arena: even when...,Some number of them turn into start-up ventures (...fueled some other creative way). After some period...ts of jobs. In fact, small businesses create more ...hows no sign of slowing. , ,It can be appealing to...
Other Biology Technology:American Family CIO takes entrepreneurial approach to innovation 2American Family CIO takes entrepreneurial approach to innovation 3American Family CIO takes entrepreneurial approach to innovation 4How to duck the 3 most common entrepreneurial hiring traps 2How to duck the 3 most common entrepreneurial hiring traps 3How to duck the 3 most common entrepreneurial hiring traps 4
(Date:12/4/2009)Scientists from the Royal Botanic Gardens, Kew and the Natural History Museum believe that carnivorous behaviour in plants is far more widespread than previously thought, with many commonly grown plan
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2How nutrition affects healthy aging 2New therapy targets for amyloid disease 2HemCon Medical Technologies Inc signs exclusive global agreement with Zimmer Dental Inc to distribute oral surgery dressings 57154 1HemCon Medical Technologies Inc signs exclusive global agreement with Zimmer Dental Inc to distribute oral surgery dressings 57154 2Hard To Treat Diseases 28HTDS 29 CUSIP Change to Force Short Sellers To Cover 57149 1Hard To Treat Diseases 28HTDS 29 CUSIP Change to Force Short Sellers To Cover 57149 2Hard To Treat Diseases 28HTDS 29 CUSIP Change to Force Short Sellers To Cover 57149 3Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 1Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 2Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 3
... of molecular signals that instructs cells with fa...53 tumor suppressor gene. If p53 is inactivated, a...and balances on cell growth fail to operate, and b...imately may lead to cancer. Not surprisingly, the ...d in great detail for many years but mainly in tis...
...ministration (FDA) announced the approval of Barac... treatment of chronic hepatitis B in adults. Chron...hepatitis B virus (HBV) that attacks the liver. Th...carring) of the liver, liver cancer, liver failure...Control and Prevention, approximately 1.25 million...
...st from the Virginia Commonwealth University Masse... at Memorial Sloan-Kettering Cancer Center, has id...lays a role in supplying nutrients to solid tumors...a greater understanding of the cell signaling that...lthy cells into helping to feed and spread growing...
Other Biology News:Cancer related gene p53 not regulated as indicated by previous tissue culture research 2Cancer related gene p53 not regulated as indicated by previous tissue culture research 3
...g System is a compact, versatile & modular instrum...cluding: Intracellular, Extracellular, Transducer...euroLog Case & Power Supply unit (NL900D) forms th... only powered by this unit, but wiring within the ...
Mouse Anti-Xenopus laevis Xenopus nuclear factor, xnf7 Antibody, Unconjugated from Developmental Studies Hybridoma Bank
PCAEC (P300-05) from European Collection of Cell Cultures (ECACC)
Goat Anti-Proliferin (N-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: